Roche, Fluidigm Ink Deal to Co-market Access Array Platform with 454 Sequencing

The worldwide co-promotional agreement pairs Fluidigm's amplicon sample preparation platform with Roche 454's high-throughput sequencers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.